Five AML cell samples showing > 50% apoptosis ex vivo had low expression of CD157; however, the correlation between CD157 expression and ex vivo survival was not statistically significant, at least in the small number of samples analysed (Supplementary Fig. S2B). This evidence concerns the gene BST1 and acute myeloid leukemia.